Monograph Details
|
|
Hematology
> Immune-mediated blood disorders
|
|
RHOGAM |
| Manufacturer |
|
Ortho Diagnostics Systems, Inc. |
| Legal Classification |
|
Rx
|
| Generic Name |
|
Rho(D) immune globulin human 300micrograms; for IM inj. |
| Also |
|
• MICRhoGAM
|
| Indications |
|
Preventing Rho(D) sensitization in nonsensitized Rho(D) negative or Du negative patients to the Rho(D) factor, following pregnancy or accidental transfusion. |
| Children |
|
See literature. |
| Adults |
|
Each vial or syringe (approx. 300micrograms) prevents sensitization to a volume of up to 15mL of Rh positive red blood cells. Administer IM at 28 weeks of gestation, within 72 hours of an Rh incompatible delivery, miscarriage, abortion, or transfusion accident. |
| Contraindications |
|
Rho(D) positive patients. |
| Precautions |
|
Pregnancy (Cat.C). |
| Adverse Reactions |
|
Local reactions. |
| How Supplied |
|
Single-dose syringes—5, 25 |
|
|
|
|
